☆ 4.6 Article

Clinical and laboratory characteristics of children with sickle cell disease on hydroxyurea treated with artemether-lumefantrine for acute uncomplicated malaria

FRONTIERS IN MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Hematology

Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa

Peter Olupot-Olupot et al.

Summary: The REACH study provides hydroxyurea at maximum tolerated dose for children with sickle cell anemia in sub-Saharan Africa, and it not only reduces SCA-related clinical events but also decreases malaria incidence by around 50%. The study analyzed the associations between hydroxyurea and lower malaria rates, through recording infections in clinical sites across Angola, Democratic Republic of Congo, Kenya, and Uganda. The results showed that ANC and splenomegaly were significant factors associated with malaria risk, and hydroxyurea treatment at MTD led to lower malaria incidence through incompletely defined mechanisms.

BLOOD (2023)

Add to Collection

Letter Gastroenterology & Hepatology

Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic

Mukul Rastogi et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)

Add to Collection

Review Multidisciplinary Sciences

Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis

Karol Marwa et al.

Summary: This study summarized the evidence of therapeutic efficacy of commonly used artemisinin-based combinations for the treatment of uncomplicated P. falciparum malaria in Sub-Saharan Africa, showing high treatment success rates above the WHO threshold value.

PLOS ONE (2022)

Add to Collection

Letter Hematology

High incidence of malaria in patients with sickle cell disease

Matilda Mkombachepa et al.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Add to Collection

Review Immunology

Neutrophils in malaria: A double-edged sword role

Kehinde Adebayo Babatunde et al.

Summary: Neutrophils play an important role in malaria, both in the defense against the malaria parasite and in the pathogenesis of the disease. However, malaria parasites inhibit the antimicrobial function of neutrophils, which may make malaria patients more susceptible to bacterial infections.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Infectious Diseases

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017-2018

Adama Gansane et al.

Summary: This study evaluated the efficacy of artemisinin-based combinations for treating uncomplicated Plasmodium falciparum malaria in Burkina Faso. Results showed inadequate efficacy of the treatments in two sites, suggesting a change of first-line ACT may be warranted.

MALARIA JOURNAL (2021)

Add to Collection

Article Infectious Diseases

Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

Chris Ebong et al.

Summary: In Uganda, DP remains highly effective and safe for the treatment of uncomplicated malaria, while monitoring of AL efficacy shows recurrent infections.

MALARIA JOURNAL (2021)

Add to Collection

Article Microbiology

Suspected Severe Malaria in a Sudanese Patient Affected by Sickle Cell Disease Who Was Treated with Hydroxyurea

Giulia Chiopris et al.

Summary: Sickle cell disease is the most common genetic disease in sub-Saharan Africa, with symptoms usually appearing in early childhood. Patients with SCD are at risk of malaria in endemic countries, and guidelines recommend antimalarial chemoprophylaxis. Hydroxyurea is considered a safe and effective treatment for SCD, although its impact on malaria incidence and severity still needs further demonstration.

PATHOGENS (2021)

Add to Collection

Article Medicine, General & Internal

Response to Hydroxyurea in a Patient With Sickle Cell Hepatopathy: A Case Report

Maha A. Safhi et al.

Summary: This case study highlights the potential benefits of hydroxyurea in improving hepatic dysfunction in sickle cell disease patients. The study follows a patient's clinical course before and after starting hydroxyurea, focusing on long-term outcomes and patterns of liver injury over a 15-year period.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Add to Collection

Article Parasitology

Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment?

Eric A. Gbessi et al.

Summary: The study assessed the effect of artemisinin derivatives on in vivo parasite clearance in individuals with different erythrocyte variants. Results showed that parasite densities and clearance rates were significantly lower in the population with abnormal hemoglobin.

PARASITE (2021)

Add to Collection

Review Immunology

The regulation of CD4+ T cells during malaria

Rajiv Kumar et al.

IMMUNOLOGICAL REVIEWS (2020)

Add to Collection

Article Infectious Diseases

Malaria in patients with sickle cell anaemia: burden, risk factors and outcome at the Laquintinie hospital, Cameroon

Ngo Linwa Esther Eleonore et al.

BMC INFECTIOUS DISEASES (2020)

Add to Collection

Article Infectious Diseases

Association between haematological parameters and sickle cell genotypes in children with Plasmodium falciparum malaria resident in Kisumu County in Western Kenya

Paul Kosiyo et al.

BMC INFECTIOUS DISEASES (2020)

Add to Collection

Review Parasitology

Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) for the Treatment of Uncomplicated Falciparum Malaria in Africa: A Systematic Review

Awoke Derbie et al.

JOURNAL OF PARASITOLOGY RESEARCH (2020)

Add to Collection

Article Pharmacology & Pharmacy

Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria

Palang Chotsiri et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection

Article Oncology

Hydroxyurea therapy in UK children with sickle cell anaemia: A single-centre experience

Kate Phillips et al.

PEDIATRIC BLOOD & CANCER (2018)

Add to Collection

Article Public, Environmental & Occupational Health

The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study

John Woodford et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)

Add to Collection

Editorial Material Hematology

Platelets in malaria pathogenesis

Jamie M. O'Sullivan et al.

BLOOD (2018)

Add to Collection

Article Infectious Diseases

Artemether-lumefantrine and liver enzyme abnormalities in non-severe Plasmodium falciparum malaria in returned travellers: a retrospective comparative study with quinine-doxycycline in a Portuguese centre

Andre Silva-Pinto et al.

MALARIA JOURNAL (2017)

Add to Collection

Article Hematology

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia

Robert O. Opoka et al.

BLOOD (2017)

Add to Collection

Article Public, Environmental & Occupational Health

Comparing the Impact of Artemisinin-Based Combination Therapies on Malaria Transmission in Sub-Saharan Africa

Martial L. Ndeffo Mbah et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)

Add to Collection

Article Medicine, General & Internal

Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

BMC MEDICINE (2015)

Add to Collection

Review Pharmacology & Pharmacy

Hydroxyurea therapy for sickle cell anemia

Patrick T. McGann et al.

EXPERT OPINION ON DRUG SAFETY (2015)

Add to Collection

Review Infectious Diseases

The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data

N. M. Anstey et al.

LANCET INFECTIOUS DISEASES (2015)

Add to Collection

Article Immunology

Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia

Daniel A. Lampah et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

Add to Collection

Article Hematology

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins

Stephane Jaureguiberry et al.

BLOOD (2014)

Add to Collection

Review Hematology

Hydroxyurea in Sickle Cell Disease: Drug Review

Rohit Kumar Agrawal et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2014)

Add to Collection

Article Infectious Diseases

A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria

George O. Adjei et al.

MALARIA JOURNAL (2014)

Add to Collection

Review Public, Environmental & Occupational Health

Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease

Ehimen C. Aneni et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)

Add to Collection

Article Medicine, General & Internal

Global Burden of Sickle Cell Anaemia in Children under Five, 2010-2050: Modelling Based on Demographics, Excess Mortality, and Interventions

Frederic B. Piel et al.

PLOS MEDICINE (2013)

Add to Collection

Letter Hematology

More definitions in sickle cell disease: Steady state v base line data

Samir K. Ballas

AMERICAN JOURNAL OF HEMATOLOGY (2012)

Add to Collection

Article Infectious Diseases

Foetal haemoglobin and the dynamics of paediatric malaria

Erica M. W. Billig et al.

MALARIA JOURNAL (2012)

Add to Collection

Article Public, Environmental & Occupational Health

Sickle Cell Disease in Africa A Neglected Cause of Early Childhood Mortality

Scott D. Grosse et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2011)

Add to Collection

Article Hematology

Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania

Sharon E. Cox et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)

Add to Collection

Review Hematology

How I use hydroxyurea to treat young patients with sickle cell anemia

Russell E. Ware

BLOOD (2010)

Add to Collection

Article Immunology

Dose-Dependent Risk of Neutropenia after 7-Day Courses of Artesunate Monotherapy in Cambodian Patients with Acute Plasmodium falciparum Malaria

Delia Bethell et al.

CLINICAL INFECTIOUS DISEASES (2010)

Add to Collection

Meeting Abstract Pediatrics

Screening newborns for sickle cell disease in Ghana

Kwaku Ohene-Frempong et al.

PEDIATRICS (2008)

Add to Collection

Article Immunology

Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation

J. M. Benito et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)

Add to Collection

Article Immunology

Effects of hydroxyurea on malaria, parasite growth and adhesion in experimental models

P. Pino et al.

PARASITE IMMUNOLOGY (2006)

Add to Collection

Article Hematology

Acute sickle cell syndromes in Nigerian adults

MO Ibidapo et al.

CLINICAL AND LABORATORY HAEMATOLOGY (2000)

Add to Collection

Article Pharmacology & Pharmacy

Inactivation of artemisinin by thalassemic erythrocytes

J Charoenteeraboon et al.

BIOCHEMICAL PHARMACOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.